MET/VEGFR-2 inhibitor GSK1363089

Definition / meaning of MET/VEGFR-2 inhibitor GSK1363089

A substance being studied in the treatment of cancer. MET/VEGFR-2 inhibitor GSK1363089 blocks enzymes involved in the growth and spread of tumor cells. It may also prevent the growth of new blood vessels that tumors need to grow. It is a type of tyrosine kinase inhibitor and a type of antiangiogenesis agent. Also called foretinib and XL880.

Listed under:

Find More About 'MET/VEGFR-2 inhibitor GSK1363089'


The Web site of the National Cancer Institute (

Leave a Comment


This site uses Akismet to reduce spam. Learn how your comment data is processed.